Jackson & Tucker, P.C.

1-866-252-3535
  • Home
  • Firm Profile
    • Representative Cases
    • FAQ
  • Our Attorneys
    • K. Stephen Jackson
    • Joseph L. “Josh” Tucker
  • Practice Areas
    • Personal Injury
    • Motor Vehicle Accidents
      • Auto Accidents
      • Motorcycle Accidents
      • Truck Accidents
    • Product Defects
      • 3M Military Earplugs
      • Essure Birth Control Implant
      • Roundup (Glyphosate) & Cancer
      • Talcum Powder & Cancer
    • Pharmaceutical Drug Litigation
      • Invokana Dangers
      • Limbrel Dangers
      • Saxenda Cancer Dangers
      • Actemra & Heart Attacks
      • Uloric Heart Attacks & Strokes
      • SGLT2 Inhibitors
      • Farxiga & Jardiance
      • Januvia, Onglyza and Tradjenta Dangers
      • Onglyza, Nesina, Kombiglyze & Heart Failure
    • Wrongful Death
    • Nursing Home & Elder Abuse
    • Consumer Fraud & Deceptive Advertising
    • Mass Torts & Class Actions
      • L’Oreal Amla NO-LYE Relaxer Kit
    • Catastrophic Injuries
      • Traumatic Brain Injuries
      • Spinal Cord Injuries
      • Burn Injuries
    • Medical Malpractice
    • Pedestrian Accidents
    • Business Litigation
  • Currently Investigating
  • Contact Us

Onglyza, Nesina, Kombiglyze & Heart Failure

An FDA safety review has determined the type 2 diabetes medicines Onglyza, Nesina, and Kombiglyze may increase the risk of heart failure, particularly in patients who already have heart or kidney disease. As a result, the FDA is adding new warnings to the drug labels about this safety issue.

Other diabetes drugs covered by this heart failure warning are:

onglyza-kombiglyze-heart failure

  • Kazano
  • Oseni

If you take Onglyza, Nesina, Kombiglyze or one of the other drugs listed above, you should contact your health care professional right away if you develop signs and symptoms of heart failure such as:

  • Unusual shortness of breath during daily activities
  • Trouble breathing when lying down
  • Tiredness, weakness, or fatigue
  • Weight gain with swelling in the ankles, feet, legs, or stomach

You should not stop taking any medicine without first talking to a health care professional. Read the FDA MedWatch Drug Safety alert.

Onglyza (Saxagliptin) was approved in for the treatment of type 2 diabetes in 2009. Since its release in 2009, Onglyza (a joint effort between AstraZeneca and Bristol-Myers Squibb) has quickly become a strong selling drug, topping $700 Million in sales in the year 2011 and over $1 Billion in 2015.

If you or a loved one have taken Onglyza, Nesina or Kombiglyze and been diagnosed with heart failure/congestive heart failure, contact us online or call 1-866-252-3535 for a free consultation.

Share this page...
  •  
  •  
  •  
  •  

How Can We Help You?

  • Privacy Policy
  • This field is for validation purposes and should be left unchanged.
Jackson & Tucker, P.C.
Black Diamond Building
2229 First Avenue North
Birmingham, AL 35203
Phone: 205-252-3535
Toll Free: 1-866-252-3535
Fax: 205-252-3536
  • Sign-up for Our Newsletter

    Get our firm and legal news sent directly to your email account!

  • This field is for validation purposes and should be left unchanged.
  • Home
  • Firm Profile
  • Our Attorneys
  • Practice Areas
  • Currently Investigating
  • Contact Us

Copyright © 2019 Jackson & Tucker, P.C. & Altrumedia, LLC · All Rights Reserved · Disclaimer